Sort by
Refine Your Search
-
Listed
-
Employer
- Delft University of Technology (TU Delft)
- Delft University of Technology (TU Delft); Delft
- University of Groningen
- Utrecht University
- University of Amsterdam (UvA)
- Eindhoven University of Technology (TU/e)
- European Space Agency
- Leiden University
- Radboud University
- University of Twente (UT)
- Delft University of Technology (TU Delft); yesterday published
- Tilburg University
- Wageningen University & Research
- Maastricht University (UM)
- University of Amsterdam (UvA); Amsterdam
- University of Twente
- Erasmus University Rotterdam
- Leiden University; 's-Gravenhage
- University of Amsterdam (UvA); today published
- Wageningen University and Research Center
- Amsterdam UMC
- Leiden University; Leiden
- NIOZ Royal Netherlands Institute for Sea Research
- Radboud University Medical Center (Radboudumc)
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- Vrije Universiteit Amsterdam (VU)
- Amsterdam UMC; 27 Sep ’25 published
- CWI
- Delft University of Technology (TU Delft); 26 Sep ’25 published
- Delft University of Technology (TU Delft); today published
- Eindhoven University of Technology (TU/e); 27 Sep ’25 published
- Erasmus MC (University Medical Center Rotterdam)
- Erasmus University Rotterdam (EUR)
- Leiden University Medical Center (LUMC)
- Maastricht University (UM); yesterday published
- Princess Máxima Center for Pediatric Oncology
- Radboud University; 3 Oct ’25 published
- Radboud University; yesterday published
- The Netherlands Cancer Institute
- University Medical Center Utrecht (UMC Utrecht)
- University Medical Center Utrecht (UMC Utrecht); Utrecht
- University Medical Center Utrecht (UMC Utrecht); yesterday published
- University of Amsterdam (UvA); 26 Sep ’25 published
- University of Amsterdam (UvA); yesterday published
- University of Groningen; 26 Sep ’25 published
- University of Twente (UT); Enschede
- Utrecht University; Utrecht
- 37 more »
- « less
-
Field
-
. To identify molecular profiles and novel drug targets in iPSC and human post-mortem brain tissue from well-characterized PD(D) patients using advanced genomic, proteomic and proteomic techniques. WP3. To aid
-
. Knowledge of Dutch and Spanish is an advantage. Other language combinations can be considered for the post. Experience with AVT tools is an advantage. An independent, proactive work ethic. A flexible, mobile
-
, internationally oriented and inclusive place to work and study. Terms and conditions We offer a full-time, fixed-term post from 01-11-2025 until 31-07-2029. Salary range from € 3.546,- to € 5.538,- gross per month
-
needs of the department, a 0.2FTE teaching contract alongside this post-doctoral appointment can be discussed. The preferred starting date is February 1st 2026, or soon thereafter. The gross monthly
-
options E-mail Pocket Viadeo Gmail Weibo Blogger Qzone YahooMail
-
options E-mail Pocket Viadeo Gmail Weibo Blogger Qzone YahooMail
-
documents: CV Motivational letter You can address your application to Viatcheslav Dobrovitski. Please note: You can apply online. We will not process applications sent by email and/or post. As part of
-
: EXPIRED X (formerly Twitter) Facebook LinkedIn Whatsapp More share options E-mail Pocket Viadeo Gmail Weibo Blogger Qzone YahooMail
-
and contribute. To apply, please send your curriculum vitae, and a two-page statement in which you clearly explain how you intend to contribute to the project, via the 'apply now' button. The candidates
-
, religious or ethnic background, gender, sexual orientation, disability or age. We strive to create a safe and inclusive environment in which everyone can flourish and contribute. To apply, please send